SCHEMBL87116

SCHEMBL87116

O=C1OC([PH](c2ccccc2)(c2ccccc2)c2ccccc2)c2c(Cl)cccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HTT P42858 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SMARCA2 P51531 1/20 0.35
SMARCA4 P51532 1/20 0.35
PBRM1 Q86U86 1/20 0.35
GUSB P08236 2/20 0.34
C1R P00736 2/20 0.34
ELANE P08246 4/20 0.33
CYP2A6 P11509 1/20 0.32
LDHA P00338 1/20 0.32
CACNB4 O00305 1/20 0.32
CACNA1A O00555 1/20 0.32
CACNA1G O43497 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23909130 0.81 C1R (0.34) ALDH1A1KMT2AC1RELANESMN1; SMN2
SCHEMBL87177 0.78 C1R (0.38) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL2309241 0.75 ALDH1A1 (0.50) ALDH1A1KMT2AHTTKDM4ELMNA
Bromide SCHEMBL29136390 0.73 ALDH1A1 (0.49) ALDH1A1KMT2AHTTKDM4ELMNA
SCHEMBL4260328 0.71 SMARCA2 (0.37) ALDH1A1MEN1KMT2AHTTNPSR1
SCHEMBL14727439 0.70 SIRT1 (0.32) ALDH1A1KMT2AHTTMAPT
SCHEMBL8005819 0.69 SMARCA2 (0.36) ALDH1A1MEN1KMT2AHTTNPSR1
SCHEMBL3890561 0.69 SMARCA2 (0.36) ALDH1A1MEN1KMT2AHTTNPSR1
SCHEMBL86920 0.69 SMARCA2 (0.36) ALDH1A1MEN1KMT2AHTTNPSR1
Bromide SCHEMBL3664289 0.68 ALDH1A1 (0.35) ALDH1A1MEN1KMT2AHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120129855-A1 PHTHALAZINONE DERIVATIVES MENEAR KEITH ALLAN (GB) 2012-05-24 US disclosed
US-8129380-B2 Phthalazinone derivatives ASTRAZENECA AB (SE) 2012-03-06 US disclosed
US-20090192156-A1 PHTHALAZINONE DERIVATIVES KUDOS PHARMACEUTICALS LIMITED (GB) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192156-A1 PHTHALAZINONE DERIVATIVES CBR1, CBR3, SDHA ALDH1A1 546/4885MEN1 905/4885KMT2A 1823/4885
US-20120129855-A1 PHTHALAZINONE DERIVATIVES CBR1, CBR3, SDHA ALDH1A1 546/4885MEN1 905/4885KMT2A 1823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.